SIC 3841 – Surgical and Medical Instruments and Apparatus
| Valuation | |
|---|---|
| Market Cap ($M) | 1.35 |
| Enterprise Value ($M) | 19.90 |
| Book Value ($M) | -11.59 |
| Book Value / Share | -0.39 |
| Price / Book | -0.12 |
| NCAV ($M) | -14.66 |
| NCAV / Share | -0.49 |
| Price / NCAV | -0.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.23 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.91 |
| Current Ratio | 2.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25.58 |
| Assets | 28.65 |
| Liabilities | 40.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 20.16 |
| Operating Income | -9.42 |
| Net Income | -9.55 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -31.66 |
| Cash from Investing | 22.15 |
| Cash from Financing | -2.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Deerfield Mgmt III, L.P. | 9.10 | ||
| 13D/A | Flynn James E | 9.10 | 0.29 | |
| 13G/A | Lytton Laurence W | 7.00 | 18.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| ABMT – Advanced BioMedical Technologies, Inc. | ADMT – ADM Tronics Unlimited, Inc. |
| ADYX – Adynxx, Inc. | AHICF – Asahi Intecc Co., Ltd. |
| ARTHQ – Arch Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io